GLP-1 receptor agonists in patients with Type 2 diabetes: cardiorenal protection versus ocular safety
Clicks: 3
ID: 318010
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.6
/100
3 views
2 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #74 of 100 articles by views in nephrology dialysis transplantation
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Elisabeth Buur Stougaard, Peter Rossing; GLP-1 receptor agonists in patients with Type 2 diabetes: cardiorenal protection versus ocular safety, Nephrology
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (19 words).
Try re-searching for a better abstract.
| Reference Key |
openalex_W7165139911
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Elisabeth B. Stougaard, Peter Rossing |
| Journal | nephrology dialysis transplantation |
| Year | 2026 |
| DOI |
10.1093/ndt/gfag131
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.